901204685	901204685	CD	B-NP	O
|	|	NN	I-NP	O
LWMMC	LWMMC	NN	I-NP	O
|	|	NN	I-NP	O
87538855	87538855	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3226632	3226632	CD	B-NP	O
|	|	CC	I-NP	O
9/13/2005	9/13/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
DEHYDRATION	DEHYDRATION	NNP	I-NP	O
,	,	,	O	O
NEUTROPENIC	NEUTROPENIC	NNP	B-NP	O
,	,	,	O	O
LUNG	LUNG	NNP	B-NP	O
CANCER	CANCER	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/26/2005	11/26/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/26/2005	10/26/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LAFUENTE	LAFUENTE	NNP	B-NP	O
,	,	,	O	O
NATHANIAL	NATHANIAL	NNP	B-NP	O
ROOSEVELT	ROOSEVELT	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Urosepsis	Urosepsis	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
AND	AND	CC	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
uterine	uterine	JJ	B-NP	O
fibroids	fibroid	NNS	I-NP	O
,	,	,	O	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bled	bled	JJ	I-NP	O
,	,	,	I-NP	O
neutropenic	neutropenic	JJ	I-NP	O
enteritis	enteritis	NN	I-NP	O
,	,	,	O	O
nonsmall	nonsmall	JJ	B-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
please	please	NN	I-NP	O
see	see	VBP	B-VP	O
the	the	DT	B-NP	O
chart	chart	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
severe	severe	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
liters	liter	NNS	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
sat	sit	VBD	B-VP	I-protein
below	below	IN	B-PP	I-protein
90s	90s	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
nonsmall	nonsmall	JJ	B-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
regimens	regimen	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
ALIMTA	ALIMTA	NN	B-NP	O
from	from	IN	B-PP	O
9/27/2005	9/27/2005	CD	B-NP	O
to	to	TO	B-PP	O
09	09	CD	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
MICU	MICU	NN	B-NP	B-DNA
on	on	IN	B-PP	O
11/26/2005	11/26/2005	CD	B-NP	O
for	for	IN	B-PP	O
neutropenia	neutropenia	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
;	;	:	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Included	Included	NNP	B-NP	O
Avapro	Avapro	NNP	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
,	,	,	O	O
Decadron	Decadron	NNP	B-NP	O
,	,	,	O	O
ranitidine	ranitidine	NN	B-NP	O
,	,	,	O	O
Humalog	Humalog	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
Alimta	Alimta	NNP	B-NP	O
,	,	,	O	O
Flonase	Flonase	NNP	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Colace	Colace	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Bactrim	Bactrim	NN	B-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
hyperkalemic	hyperkalemic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
penicillin	penicillin	NN	B-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
anaphylaxis	anaphylaxis	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
15	15	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	NN	B-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
stroke	stroke	NN	B-NP	O
,	,	,	O	O
thyroid	thyroid	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cervical	cervical	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

FINDINGS	FINDINGS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Shows	Show	VBZ	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.9	98.9	CD	B-NP	O
.	.	.	O	O

pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
116	116	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
84/47	84/47	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
ventilation	ventilation	NN	B-NP	O
.	.	.	O	O

General	General	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
intubated	intubated	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
awake	awake	JJ	I-ADJP	O
,	,	,	O	O
motioning	motion	VBG	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
tube	tube	NN	I-NP	O
out	out	RP	B-PRT	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
scattered	scattered	JJ	B-NP	O
group	group	NN	I-NP	O
petechial	petechial	JJ	I-NP	O
areas	area	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
torso	torso	NN	I-NP	O
,	,	,	O	O
abdomen	abdomen	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NNP	B-NP	O
Exam	Exam	NNP	I-NP	O
shows	show	VBZ	B-VP	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
anicteric	anicteric	JJ	I-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
JVP	JVP	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
expiratory	expiratory	JJ	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
few	few	JJ	B-NP	O
scattered	scattered	JJ	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
tachycardia	tachycardia	NN	B-NP	O
otherwise	otherwise	RB	B-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
across	across	IN	B-PP	O
precordium	precordium	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
pannus	pannus	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
show	show	VBP	B-VP	O
trace	trace	NN	B-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shins	shin	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
awake	awake	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
being	be	VBG	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

PERTINENT	PERTINENT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Show	Show	VB	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
0.74	0.74	CD	B-NP	O
with	with	IN	B-PP	O
46	46	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
and	and	CC	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
neutrophil	neutrophil	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
340	340	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
26.2	26.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
37	37	CD	B-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
of	of	IN	B-PP	O
3.1	3.1	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
83.5	83.5	CD	B-NP	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
shows	show	VBZ	B-VP	O
right	right	JJ	B-NP	O
infrahilar	infrahilar	JJ	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
alveolar	alveolar	JJ	I-NP	O
disease	disease	NN	I-NP	O
versus	versus	IN	B-PP	O
new	new	JJ	B-NP	O
fusions	fusion	NNS	I-NP	O
,	,	,	O	O
I	I	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
infiltrate	infiltrate	NN	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
shows	show	VBZ	B-VP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
wall	wall	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
and	and	CC	O	O
left-sided	left-sided	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
intubation	intubation	NN	I-NP	O
and	and	CC	I-NP	O
extubation	extubation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Dozois	Dozois	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
I	I	PRP	B-NP	O
was	be	VBD	B-VP	O
concerned	concern	VBN	I-VP	O
for	for	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
,	,	,	O	O
I	I	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
thought	think	VBD	B-VP	O
nosocomial	nosocomial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
versus	versus	IN	B-PP	O
GI	GI	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
and	and	CC	I-NP	O
pressors	pressor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Levaquin	Levaquin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
aztreonam	aztreonam	NN	B-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
empirically	empirically	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
grew	grow	VBD	B-VP	O
Enterococcus	Enterococcus	NNP	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
6/21/2005	6/21/2005	CD	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
an	an	DT	B-NP	O
enterococcal	enterococcal	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
nosocomial	nosocomial	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
wall	wall	NN	I-NP	O
thickening	thickening	NN	I-NP	O
and	and	CC	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SMA	SMA	NN	I-NP	O
territory	territory	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
enteritis	enteritis	NN	I-NP	O
.	.	.	O	O

Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
conservatively	conservatively	RB	B-ADVP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
rest	rest	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	B-ADJP	O
longer	longer	RB	I-ADJP	O
neutropenic	neutropenic	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
off	off	JJ	B-NP	O
Neupogen	Neupogen	NN	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
stay	stay	VB	I-VP	O
and	and	CC	I-VP	O
finish	finish	VB	I-VP	O
the	the	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Lorts	Lorts	NNP	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
rest	rest	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
enteritis	enteritis	NN	I-NP	O
and	and	CC	O	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADJP	O
longer	longer	RBR	I-ADJP	O
neutropenic	neutropenic	JJ	I-ADJP	O
without	without	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clear	clear	JJ	B-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
likely	likely	JJ	B-NP	O
sloughing	sloughing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mucosa	mucosa	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
neutropenic	neutropenic	JJ	I-NP	O
enteritis	enteritis	NN	I-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
bowel	bowel	NN	B-NP	O
rest	rest	NN	I-NP	O
.	.	.	O	O

Though	Though	IN	B-SBAR	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	O
also	also	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
culprit	culprit	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
is	be	VBZ	B-VP	O
mucosal	mucosal	JJ	B-NP	O
sloughing	sloughing	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
bloody	bloody	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
whenever	whenever	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
re	re	NN	B-NP	O
challenged	challenge	VBN	B-VP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
C-diff	C-diff	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Colonoscopy	Colonoscopy	NN	B-NP	O
was	be	VBD	B-VP	O
deferred	defer	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
26	26	CD	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
unstable	unstable	JJ	I-ADJP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-SBAR	O
given	give	VBN	B-NP	O
sustained	sustained	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
rest	rest	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
stools	stool	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
oral	oral	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
9/6/2005	9/6/2005	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
wall	wall	NN	I-NP	O
thickening	thickening	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
intraabdominal	intraabdominal	JJ	I-NP	O
process	process	NN	I-NP	O
causing	cause	VBG	B-VP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
regular	regular	JJ	B-NP	O
diet	diet	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
without	without	IN	B-PP	O
problems	problem	NNS	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
typically	typically	RB	B-ADVP	O
requiring	require	VBG	B-VP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
sat	sit	VBD	B-VP	O
over	over	IN	B-PP	O
90s	90	NNS	B-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Shubrick	Shubrick	NNP	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
8/22/2005	8/22/2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
requires	require	VBZ	B-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
induced	induce	VBD	B-VP	O
anemia	anemia	NN	B-NP	O
with	with	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
drop	drop	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
21	21	CD	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
around	around	IN	B-NP	O
26	26	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
initially	initially	RB	B-ADVP	O
to	to	TO	B-PP	O
three	three	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
over	over	IN	B-PP	O
10/18/2005	10/18/2005	CD	B-NP	O
and	and	CC	I-NP	O
09	09	CD	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
sloughing	slough	VBG	I-NP	O
mucosa	mucosa	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
resolving	resolve	VBG	B-VP	O
neutropenic	neutropenic	JJ	B-NP	O
enteritis	enteritis	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
chemo	chemo	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
further	further	JJ	I-NP	O
RBC	RBC	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
thrombocytopenic	thrombocytopenic	JJ	B-ADJP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
chemo	chemo	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
platelet	platelet	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
suboptimal	suboptimal	JJ	B-NP	O
busted	bust	VBN	I-NP	O
platelet	platelet	NN	I-NP	O
levels	level	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
marrow	marrow	NN	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
chemo	chemo	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
possible	possible	JJ	I-NP	O
causes	cause	VBZ	B-VP	O
refractory	refractory	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	B-PP	O
possible	possible	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
respectively	respectively	RB	B-ADVP	O
at	at	IN	B-PP	O
29.8	29.8	CD	B-NP	O
and	and	CC	I-NP	O
46	46	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
a	a	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
in	in	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
creatine	creatine	NN	I-NP	O
is	be	VBZ	B-VP	O
1.7	1.7	CD	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
3	3	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
hypovolemia	hypovolemia	NN	B-NP	O
from	from	IN	B-PP	O
vomiting	vomiting	NN	B-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FENa	FENa	NNP	I-NP	O
was	be	VBD	B-VP	O
0.22	0.22	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
with	with	IN	B-PP	O
hydration	hydration	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nonsmall	Nonsmall	JJ	B-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Alimta	Alimta	NNP	B-NP	O
started	start	VBD	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
neutropenia	neutropenia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
since	since	IN	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Ervin	Ervin	NNP	I-NP	O
Tonrey	Tonrey	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
portland	portland	NN	B-NP	O
protocol	protocol	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Steroids	Steroid	NNS	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
6/21/2005	6/21/2005	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
passed	pass	VBD	B-VP	O
a	a	DT	B-NP	O
cortisol	cortisol	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
6/21/2005	6/21/2005	CD	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
standing	stand	VBG	B-VP	O
insulin	insulin	NN	B-NP	B-protein
on	on	IN	B-PP	O
6/21/2005	6/21/2005	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Lantus	Lantus	NNP	I-NP	O
was	be	VBD	B-VP	O
up	up	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80s	CD	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
120s	120s	CD	B-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
TPN	TPN	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
10/4/2005	10/4/2005	CD	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
bowel	bowel	NN	I-NP	O
rest	rest	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
enteritis	enteritis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
on	on	IN	B-PP	O
10/16/2005	10/16/2005	CD	B-NP	O
and	and	CC	O	O
tolerated	tolerate	VBN	B-VP	O
advancement	advancement	NN	B-NP	O
to	to	TO	B-PP	O
diabetic	diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
TPN	TPN	NN	I-NP	B-protein
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
,	,	,	O	O
Hematology	Hematology	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
max	max	NN	I-NP	O
98	98	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/60	120/60	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
88	88	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
sating	sate	VBG	B-VP	O
at	at	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3.5	3.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

General	General	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	JJ	I-NP	O
resting	resting	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Nasal	Nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NNP	B-NP	O
Exam	Exam	NNP	I-NP	O
was	be	VBD	B-VP	O
normocephalic	normocephalic	JJ	B-ADJP	O
,	,	,	O	O
atraumatic	atraumatic	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
air	air	NN	I-NP	O
entry	entry	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
otherwise	otherwise	RB	B-NP	O
no	no	DT	I-NP	O
obvious	obvious	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchus	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
decreased	decrease	VBD	B-VP	O
heart	heart	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
show	show	VBP	B-VP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
area	area	NN	I-NP	B-cell_line
where	where	WRB	B-ADVP	I-cell_line
left	left	JJ	B-NP	I-cell_line
internal	internal	JJ	I-NP	I-cell_line
jugular	jugular	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
and	and	CC	O	O
dressed	dress	VBN	B-VP	O
.	.	.	O	O

Improved	Improve	VBN	B-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
intertriginous	intertriginous	JJ	I-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
focal	focal	JJ	I-NP	O
neurologic	neurologic	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Marco	Marco	NNP	I-NP	O
Derosset	Derosset	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	B-NP	O
to	to	TO	I-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
fever	fever	NN	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
Peridex	Peridex	NNP	B-NP	O
mouth	mouth	NN	I-NP	O
wash	wash	NN	I-NP	O
10	10	CD	B-NP	O
mL	mL	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
mouth	mouth	NN	I-NP	O
wash	wash	NN	I-NP	O
10	10	CD	I-NP	O
mL	mL	NN	I-NP	O
swish	swish	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
4	4	CD	B-NP	O
x	x	NN	I-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
q.	q.	FW	I-NP	I-protein
6h	6h	FW	I-NP	I-protein
p.r.n.	p.r.n.	FW	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
simethicone	simethicone	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
gaseousness	gaseousness	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
to	to	TO	B-PP	O
areas	area	NNS	B-NP	O
between	between	IN	B-PP	O
skin	skin	NN	B-NP	O
folds	fold	NNS	I-NP	O
including	include	VBG	B-PP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
Nebs	Neb	NNS	I-NP	O
q.	q.	VBP	B-VP	O
3	3	CD	B-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
aspart	aspart	NN	B-NP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
meclizine	meclizine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
125	125	CD	I-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-3330661	1-3330661	CD	B-NP	O
AFFocus	AFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SPAHN	SPAHN	NN	B-NP	B-protein
,	,	,	O	O
LELAND	LELAND	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHEURING	SCHEURING	NNP	B-NP	O
,	,	,	O	O
WILLY	WILLY	NNP	B-NP	O
LYMAN	LYMAN	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8581453	8581453	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/16/05	7/16/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/16/05	2/16/05	CD	B-NP	O

